Weight and metabolic changes after switching from tenofovir alafenamide/emtricitabine (FTC)+dolutegravir (DTG), tenofovir disoproxil fumarate (TDF)/FTC+DTG and TDF/FTC/efavirenz (EFV) to TDF/lamivudine /DTG

B BoschGodspower AkpomiemieNomathemba ChandiwanaSimiso SokhelaA HillK McCannA QaviE et alWillem Venter2024-07-232024-07-23WOS1058-4838https://hdl.handle.net/10539/39057Weight and metabolic changes after switching from tenofovir alafenamide/emtricitabine (FTC)+dolutegravir (DTG), tenofovir disoproxil fumarate (TDF)/FTC+DTG and TDF/FTC/efavirenz (EFV) to TDF/lamivudine /DTGJournal Article